CAS 97979-65-2

Etaqualone Hydrochloride

Controlled Product

CAS: 97979-65-2

Applications An analogue of Methaqualone (M225900) with sedative and hypnotic properties, and used for the treatment of insomnia.
References Squires, R. et al.: Neurochem. Res., 25, 1587 (2000); Pflegel, P. et al.: Pharmazie, 22, 643 (1967); Kuhnert-Brandstaetter, M. et al.: Microchem. J., 17, 739 (1972);

Formula: C₁₇H₁₇ClN₂O

Color and Shape: Neat

Molecular weight: 300.78

Ref: TR-E673500

Etaqualone-d3 Hydrochloride (Major)

Controlled Product

CAS: 97979-65-2

Applications The labelled derivative of a Methaqualone (M225900) analogue with sedative and hypnotic properties, and used for the treatment of insomnia.
References Squires, R. et al.: Neurochem. Res., 25, 1587 (2000); Pflegel, P. et al.: Pharmazie, 22, 643 (1967); Kuhnert-Brandstaetter, M. et al.: Microchem. J., 17, 739 (1972);

Formula: C₁₇D₃H₁₃N₂O·HCl

Color and Shape: Neat

Molecular weight: 303.801

Ref: TR-E673502

Etaqualone hydrochloride

Controlled Product

CAS: 97979-65-2

Etaqualone is a water-soluble, white crystalline powder that is soluble in alcohol, acetone, chloroform, ethers, and petroleum ether. It has no odor or taste and does not burn the skin. Etaqualone has been used to treat inflammatory bowel disease and for the treatment of infectious diseases such as malaria. The drug binds to the D2 dopamine receptor and stimulates the release of dopamine in the brain. This action leads to side effects such as drowsiness, dizziness, nausea, vomiting, blurred vision, and convulsions.
The name etaqualone is derived from its chemical structure: 2-(2-chlorophenyl)-3-(2-methoxyphenyl)-5-methyloxazolidin-4-one hydrochloride.

Formula: C₁₇H₁₆N₂O

Purity: Min. 95%

Molecular weight: 264.32 g/mol

Ref: 3D-FE22845